Elo strongly promoted degranulation of NK cells that required integrity of the Fc domain and correlated with SLAMF7 expression level on the myeloma cells, thereby confirming that the main mechanism of action of Elo is NK cell-mediated ADCC (39). The gene discussed is SLAMF7; the disease is plasma cell myeloma.